Primary and salvage cryotherapy for prostate cancer

David S Finley; Frederic Pouliot; David C Miller; Arie S Belldegrun

doi:10.1016/j.ucl.2009.11.007

Primary and salvage cryotherapy for prostate cancer

Urol Clin North Am. 2010 Feb;37(1):67-82, Table of Contents. doi: 10.1016/j.ucl.2009.11.007.

Authors

David S Finley¹, Frederic Pouliot, David C Miller, Arie S Belldegrun

Affiliation

¹ Department of Urology, Institute of Urologic Oncology, David Geffen School of Medicine at UCLA, 924 Westwood Boulevard, Suite 1050, Box 957207, Los Angeles, CA 90095-7207, USA. dfinley@mednet.ucla.edu

PMID: 20152521
DOI: 10.1016/j.ucl.2009.11.007

Abstract

Cryotherapy is a technique to ablate tissue by local induction of extremely cold temperatures. Recently, the American Urological Association Best Practice Statement recognized cryoablation of the prostate as an established treatment option for men with newly diagnosed or radiorecurrent organ-confined prostate cancer. Emerging data suggest that, in select cases, cryoablation may have a role in focal ablation of prostate. The current state of the art of cryoablation in these applications is reviewed.

Publication types

Review

MeSH terms

Cryotherapy / adverse effects
Cryotherapy / methods*
Humans
Male
Neoplasm Recurrence, Local / therapy*
Prostatic Neoplasms / therapy*
Quality of Life
Salvage Therapy
Treatment Outcome